Title |
Radiotherapy and chemoradiation after surgery for early cervical cancer
|
---|---|
Published in |
Cochrane database of systematic reviews, May 2012
|
DOI | 10.1002/14651858.cd007583.pub3 |
Pubmed ID | |
Authors |
Linda Rogers, Shing Shun N Siu, David Luesley, Andrew Bryant, Heather O Dickinson |
Abstract |
This is an updated version of the original Cochrane review first published in Issue 4, 2009. There is an ongoing debate about the indications for, and value of, adjuvant pelvic radiotherapy after radical surgery in women with early cervical cancer. Certain combinations of pathological risk factors are thought to represent sufficient risk for recurrence, that they justify the use of postoperative pelvic radiotherapy, though this has never been shown to improve overall survival, and use of more than one type of treatment (surgery and radiotherapy) increases the risks of side effects and complications. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 50% |
Serbia | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Ecuador | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 247 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 34 | 14% |
Unspecified | 33 | 13% |
Student > Master | 27 | 11% |
Researcher | 17 | 7% |
Other | 15 | 6% |
Other | 56 | 22% |
Unknown | 67 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 97 | 39% |
Unspecified | 33 | 13% |
Nursing and Health Professions | 21 | 8% |
Biochemistry, Genetics and Molecular Biology | 8 | 3% |
Agricultural and Biological Sciences | 7 | 3% |
Other | 15 | 6% |
Unknown | 68 | 27% |